Japan's Otsuka to buy Avanir for $3.5 billion ahead of patent cliff

mardi 2 décembre 2014

Receptionist works at the Otsuka Holdings Co headquarters in Tokyo (Reuters) - Japanese drugmaker Otsuka Holdings Co Ltd plans to buy U.S.-based Avanir Pharmaceuticals Inc for about $3.5 billion (2.2 billion pounds) to expand its neurologic drug portfolio ahead of an ...








via Business News http://ift.tt/1yecUfw

0 commentaires:

Enregistrer un commentaire